WEST DES MOINES, IA / ACCESSWIRE / August 27, 2014 / Spotlight Innovation, Inc. (OTCQB: STLT) today published a white paper reporting the progress and growth of the transfer and commercialization of university-generated research and intellectual property (IP). Midwest Universities are Cultivating IP Commercialization Success explores how the changing policies of the federal government in conjunction with innovations from the academic and business communities are creating new opportunities for Universities, researchers and other stakeholders to turn transformative ideas into profitable business ventures.
Cristopher Grunewald, President and CEO of Spotlight Innovation said, "The relatively recent emphasis from the federal government on commercialization of federally-funded intellectual property is creating new licensing agreements, start-up companies and impactful products at an accelerating pace. The Midwest, with a rich history in research and academia, is well-positioned to drive IP commercialization efforts that will have a positive economic impact, and in the healthcare space, have a positive impact on health and wellbeing."
White paper excerpt:
Working together, research institutions, private-sector entities and government are advancing efforts to develop innovative and substantive commercialization programs. And these efforts are reaping rewards, driving an uptick in technology transfer from universities to industry, and ultimately to the public.
The paper is available at http://www.spotlightinnovation.com/download-whitepaper
About Spotlight Innovation, Inc.
Spotlight Innovation, Inc. (OTCQB: STLT) specializes in identifying, acquiring and incubating companies that have unique intellectual property (IP) in the medical sector. The Company utilizes relationships with the nation's leading academic and institutional IP developers to locate promising IP technologies with potential for market share capture. With our support, development resources and strategic planning expertise we believe we can develop IP that will have a positive effect on healthcare. We intend to partner with proven sector leaders on commercialization once technologies are fully developed. Additional information available at www.spotlightinnovation.com.
Forward Looking Statements
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.
Press Contact
Rene Erickson
Spotlight Innovation, Inc.
1-515-274-9087
[email protected]
Investor Relations Contact
Mike Reysack
Spotlight Innovation, Inc.
1-641-512-1035
[email protected]
SOURCE: Spotlight Innovation, Inc.